TLR8 agonist 4 对野生型和耐药（拉米夫定和恩替卡韦）HBV菌株均表现出有效的抑制作用。其IC50值分别为 0.15 和 0.10 μM。

TLR8 agonist 4 showed effective inhibition on wild-type and drug-resistant (lamivudine and entecavir) HBV strains. The IC 50 values are 0.15 and 0.10 respectively μM.

C28H27N5O5S

545.61

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years